LAZARD ASSET MANAGEMENT LLC - AERIE PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
LAZARD ASSET MANAGEMENT LLC ownership history of AERIE PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2022$109,000
+84.7%
7,248
-8.0%
0.00%
Q2 2022$59,000
+181.0%
7,877
+158.4%
0.00%
Q4 2021$21,000
-65.0%
3,048
-10.6%
0.00%
Q1 2021$60,000
-60.3%
3,410
-69.6%
0.00%
Q4 2020$151,00011,2210.00%
Other shareholders
AERIE PHARMACEUTICALS INC shareholders Q4 2022
NameSharesValueWeighting ↓
JACOB ASSET MANAGEMENT OF NEW YORK LLC 246,563$2,244,0001.36%
LEVIN CAPITAL STRATEGIES, L.P. 1,435,876$13,066,0001.26%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 4,695,020$42,725,0000.96%
DCF Advisers, LLC 189,565$1,725,0000.76%
DAFNA Capital Management LLC 289,040$2,630,0000.68%
RICE HALL JAMES & ASSOCIATES, LLC 1,678,609$15,275,0000.61%
Rhenman & Partners Asset Management AB 589,200$5,362,0000.53%
PFM Health Sciences, LP 1,088,566$9,906,0000.37%
NEXPOINT ASSET MANAGEMENT, L.P. 309,778$2,819,0000.36%
Granahan Investment Management 1,588,944$14,459,0000.36%
View complete list of AERIE PHARMACEUTICALS INC shareholders